Primary Central Nervous System Lymphoma Clinical Trials in Hanzhou, Zhejiang
2 recruitingHanzhou, Zhejiang, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma
Relapsed/Refractory Primary Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University38 enrolled1 locationNCT06556199
Recruiting
Phase 2
Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
Primary Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University28 enrolled1 locationNCT05600660